After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be ... to cause a spike in blood sugar and diabetic ketoacidosis. Both of those actions could ...

That has left Medtronic and others in the insulin pump market scrambling to catch ... those who want to use technology to make living with diabetes easier.” Now, the company will have to look ...

It estimates about 18,000 New Zealanders living with type 1 diabetes could benefit from the idea. But it is also proposing to stop funding the Medtronic brand of insulin pump used by 2000 people ...

Head of Diabetes New Zealand Heather Verry ... agency to reconsider the decision to stop funding the Medtronic brand of insulin pumps currently worn by nearly 2000 people. Martin said Pharmac ...

Insulin pump therapy ... novel diagnostic and therapeutic options for diabetes therapy, including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.

Diabetes is Medtronic's smallest segment by revenue, but it has been growing faster than the rest of its business for a while. The recent boost is partly due to Medtronic's newest insulin pump ...

About 12,000 New Zealanders with diabetes are expected to get ... From January 1, 2025, the Medtronic MiniMed 770G insulin pump will no longer be funded for people new to insulin pumps.

Medtronic Plc is a medical technology ... and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables.

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Medtronic faced challenges ... The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article. This, combined with competition from pod-based ...

Medtronic hasn't been growing its sales at an impressive clip of late. However, one of the company's segments looks increasingly promising. Medtronic has other growth opportunities and is a solid ...